Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
about
TLR2 controls intestinal carcinogen detoxication by CYP1A1Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetesEET signaling in cancerVascular actions of 20-HETE20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel20-HETE and blood pressure regulation: clinical implicationsCYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activitiesStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerSoluble epoxide hydrolase-dependent regulation of myogenic response and blood pressureCerebral microhemorrhages: mechanisms, consequences, and prevention.Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injuryTargeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems.20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in ratsRationally designed multitarget agents against inflammation and pain.Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke.The role of 20-HETE in androgen-mediated hypertension.20-HETE-producing enzymes are up-regulated in human cancers.Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteriesCYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation.20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis.20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension.PharmGKB summary: very important pharmacogene information for CYP4F2Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway.Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men.20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathwayDown-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats
P2860
Q21090942-132C411A-4D78-4661-B370-56FDA0D39CFCQ28081462-909A8C04-146A-4AFD-9808-DA5957CBF616Q28250730-B76A1550-C532-4BDE-BC6E-6845A82A1057Q28259468-FD0B4FB7-F14C-4C6D-AC79-9E3A9FBC1606Q28261243-483A27C9-E06E-4BB2-83E3-C882E9002C2EQ28288942-FA6889F1-BFDF-48BB-9937-2CA94CD9E877Q28290987-43EFAFF3-5852-4ACC-AAA4-43542F9F0100Q28304230-9DB44C39-AAAA-4A95-AFB3-8D0FF7D53A6DQ28384214-5E9E0E1A-C661-4784-8FC3-2A6D8A2C8D75Q30235220-C287C56E-6520-49A5-93A1-5608FBE2AD09Q33389156-E1F919C3-D020-4F8B-A789-8FBB075290F6Q33442367-BB639BCA-AF70-4283-858D-1B0D46AB4151Q33443229-807BD4C0-AFDE-48C2-B271-BC73255EA5AEQ33574917-EFE33EBE-413A-4B7C-990B-4DDFE1CFD92AQ33636288-6A6B0718-4F62-4D13-ADAC-33556A878C77Q33671358-12C67AA2-F757-48CE-B7BE-DDC6B58FE1EBQ33714587-C5B88A1E-F442-4C10-A69E-814971F543F9Q33772181-48BE100E-2312-46E4-8241-9B89AE665B49Q33775129-646B80BE-84C0-4CE1-8D9C-09D33C6204A9Q33900988-C34BE3B8-7E2B-472A-AFF5-B7B322DABD67Q33960685-7CE070C9-9FB4-40AD-BB3E-6CC848AE3985Q34143118-AD0B5D20-A407-4502-AF21-210ADC5F7DABQ34152658-6B797102-C3AB-4058-978B-C7374AEB00E5Q34188431-C629A7FB-BA01-4A8C-9D71-B55F8AC3A051Q34196923-F4843608-DA90-49DC-9F46-7F88B8D9E232Q34288316-8B130694-B3E2-4987-9E2F-A7F712EDD275Q34338086-8E1302C1-C34B-45C6-A422-2B9143D20AC5Q34343723-47489CB6-7D12-414D-9F46-142A7C62ED57Q34369965-915315E7-4B5F-44BD-BF17-4843D14843BFQ34426173-20877ADA-26B5-4185-A6E4-0A2D1000C1E8Q34440126-7C846B1B-872C-4F30-B10E-56D8FD41A6C1Q34469211-FA6998A7-E1AC-476F-A8D1-44708D3CB3B5Q34553783-304A2251-7650-498F-80C4-2E9D6CB56C9DQ34664072-5D27EC90-5DE2-47D5-A227-64A051A9E5B7Q34715847-D302F354-73F1-4C2A-859F-2E4CA374C3C7Q34780122-36B829FB-6C05-488A-BC3E-609096FF6F21Q34826145-AF4DD2D4-7142-4FBD-927B-AD1ECFDE60BBQ34924935-64C6F102-F984-4F7E-83B0-AA8CD19650FFQ35008976-B29F06E4-156D-400A-BE42-6345201BF74CQ35057234-AD2D4210-373F-4B7B-AC9A-965E5DFFFF05
P2860
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@ast
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@en
Role of 20-hydroxyeicosatetraenoic acid
@nl
type
label
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@ast
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@en
Role of 20-hydroxyeicosatetraenoic acid
@nl
prefLabel
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@ast
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@en
Role of 20-hydroxyeicosatetraenoic acid
@nl
P356
P1476
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
@en
P2093
Noriyuki Miyata
Richard J Roman
P304
P356
10.1540/JSMR.41.175
P577
2005-08-01T00:00:00Z